Facioscapulohumeral muscular dystrophy: genetics, gene activation and downstream signalling with regard to recent therapeutic approaches: an update

Whilst a disease-modifying treatment for Facioscapulohumeral muscular dystrophy (FSHD) does not exist currently, recent advances in complex molecular pathophysiology studies of FSHD have led to possible therapeutic approaches for its targeted treatment. Although the underlying genetics of FSHD have...

Descripción completa

Detalles Bibliográficos
Autores principales: Schätzl, Teresa, Kaiser, Lars, Deigner, Hans-Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7953708/
https://www.ncbi.nlm.nih.gov/pubmed/33712050
http://dx.doi.org/10.1186/s13023-021-01760-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7953708/
https://www.ncbi.nlm.nih.gov/pubmed/33712050
http://dx.doi.org/10.1186/s13023-021-01760-1

Ejemplares similares